Organon & Co. (OGN)
13.76
+0.02
(+0.15%)
USD |
NYSE |
Oct 15, 16:00
13.76
0.00 (0.00%)
After-Hours: 20:00
Organon Cash from Operations (TTM) : 737.00M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 737.00M |
| March 31, 2026 | 850.00M |
| December 31, 2025 | 700.00M |
| September 30, 2025 | 949.00M |
| June 30, 2025 | 826.00M |
| March 31, 2025 | 938.00M |
| December 31, 2024 | 939.00M |
| September 30, 2024 | 946.00M |
| June 30, 2024 | 1.066B |
| March 31, 2024 | 761.00M |
| December 31, 2023 | 799.00M |
| September 30, 2023 | 669.00M |
| Date | Value |
|---|---|
| June 30, 2023 | 725.00M |
| March 31, 2023 | 849.00M |
| December 31, 2022 | 858.00M |
| September 30, 2022 | 772.00M |
| June 30, 2022 | 525.00M |
| March 31, 2022 | 1.846B |
| December 31, 2021 | 2.458B |
| September 30, 2021 | 2.664B |
| June 30, 2021 | 2.925B |
| March 31, 2021 | 2.256B |
| December 31, 2020 | 2.187B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Merck & Co., Inc. | 19.97B |
| Viatris, Inc. | 2.331B |
| Pfizer Inc. | 13.40B |
| Pacira Biosciences, Inc. | 187.66M |
| Bristol Myers Squibb Co. | 12.78B |